Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407
Dissolution behaviour of a poorly water-soluble drug, tadalafil, from its solid dispersion systems with poloxamer 407 has been investigated. Solid dispersion systems of tadalafil were prepared with poloxamer 407 in 1:0.5, 1:1.5 and 1:2.5 ratios using the melting method. Characterization of binary systems with FTIR and XRPD studies demonstrated the presence of strong hydrogen bonding interactions, a significant decrease in crystallinity and the possibility of existence of amorphous entities of the drug. In the binary systems tested, 1:0.5 proportion of tadalafil/poloxamer 407 showed rapid dissolution of tadalafil (DE30 70.9 ± 3.6 %). In contrast, higher proportions of poloxamer 407 (1:1.5 and 1:2.5) offered no advantage towards dissolution enhancement of the drug, indicating altered rheological characteristics of the polymer at its higher concentration, which might have retarded the release rate of tadalafil.
D. A. Hussar, New drugs of 2003, J. Am. Pharm. Assoc. 44 (2004) 168-206; DOI: 10.1331/154434504773062627.
H. Porst, H. Padma-Nathan, F. Giuliano, G. Anglin, L. Varanese and R. Rosen, Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial, Urology 62 (2003) 121-125; DOI: 10.1016/S0090-4295(03)00359-5.
H. Schott, L. C. Kwan and S. Feldman, The role of surfactant in the release of very slightly soluble drugs from tablets, J. Pharm. Sci. 71 (1982) 1038-1045; DOI: 10.1002/jps.2600710921.
F. Veiga, J. J. C. Teixeria-Dias, F. Kedzeierewicz, A. Sousa and P. Maincent, Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin, Int. J. Pharm. 129 (1996) 63-71; DOI: 10.1016/0378-5173(95)04243-1.
J. O. Henck, U. J. Griesser and A. Burger, Polymorphie von Arzneistoffen eine wirtschaftliche Herausforderung?, Pharm. Ind. 59 (1997) 165-169.
L. Christian and J. Dressman, Improving drug solubility for oral delivery using solid dispersions, Eur. J. Pharm. Biopharm. 50 (2000) 47-60; DOI: 10.1016/S0939-6411(00)00076-X.
D. Q. M. Craig, The mechanisms of drug release from solid dispersions in water-soluble polymers, Int. J. Pharm. 231 (2002) 131-144; DOI: 10.1016/S0378-5173(01)00891-2.
M. Newa, K. H. Bhandari, D. X. Li, T. H. Kwon, J. A. Kim, B. K. Yoo, J. S. Woo, W. S. Lyoo, C. S. Yong and H. G. Choi, Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188, Int. J. Pharm. 343 (2007) 228-237; DOI: 10.1016/j.ijpharm.2007.05.031.
G. Dumortier, J. L. Grossiord, F. Agnely and J. C. Chaumeil, A review of poloxamer 407 pharmaceutical and pharmacological characteristics, Pharm. Res. 23 (2006) 2709-2728; DOI: 10.1007/s11095-006-9104-4.
D. S. Singhare, S. Khan and P. G. Yeole, Poloxamers: Promising block co-polymers in drug delivery, Indian J. Pharm. Sci. 67 (2005) 523-531.
J. L. Ford, The current status of solid dispersions, Pharm. Acta Helv. 61 (1986) 69-88.
J. A. Ryan, Compressed pellet X-ray diffraction monitoring for optimisation of crystallinity in lyophilised solids: imipenem: cilastatin sodium case, J. Pharm. Sci. 75 (1986) 805-807; DOI: 10.1002/jps.2600750817.
Y. J. Park, C. S. Yong, H. M. Kim, J. D. Rhee, Y. K. Oh, C. K. Kim and H. G. Choi, Effect of sodium chloride on the release, absorption and safety of diclofenac sodium delivered by poloxamer gel, Int. J. Pharm. 263 (2003) 105-111; DOI: 10.1016/S0378-5173(03)00362-4.
G. Mooter, P. Augustijns, N. Blaton and R. Kinget, Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30, Int. J. Pharm. 164 (1998) 67-80; DOI: 10.1016/S0378-5173(97)00401-8.
T. Save and P. Venkitachalam, Studies on solid dispersions of nifedipine, Drug Dev. Ind. Pharm. 18 (1992) 1663-1679; DOI: 10.3109/03639049209040893.